Video laryngeal mask versus endotracheal tube for airway management during septoplasty
Comparison of Video Laryngeal Mask Airway and Endotracheal Tube Use for Airway Safety in Patients Undergoing Septoplasty
This study tests whether a video laryngeal mask or a standard endotracheal tube better prevents airway blood contamination and reduces throat soreness in adults having elective septoplasty.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 64 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Samsun University Academic / other |
| Locations | 1 site (Samsun, Ilkadim) |
| Trial ID | NCT06950957 on ClinicalTrials.gov |
What this trial studies
This is a prospective, randomized comparison of a video-assisted supraglottic airway (VLMA) versus a conventional endotracheal tube (ETT) in adults aged 18–65 with ASA I–II undergoing elective septoplasty. Participants are randomly assigned to receive VLMA or ETT under standardized general anesthesia with BIS monitoring and routine perioperative monitoring. The primary outcome is presence of blood contamination in the glottic and subglottic regions at the end of surgery, and secondary outcomes include hemodynamic responses, ventilation parameters, and postoperative airway symptoms such as sore throat and hoarseness. Respiratory and cardiovascular variables are recorded at predefined time points to compare safety and performance of the two airway devices.
Who should consider this trial
Good fit: Adults 18–65 years old with ASA physical status I–II scheduled for elective septoplasty who do not have a predicted difficult airway, BMI >30, GERD/hiatal hernia, or pregnancy are ideal candidates.
Not a fit: Patients with anticipated difficult airway, ASA III–IV status, BMI over 30, a history of GERD/hiatal hernia, or who are pregnant were excluded and are unlikely to benefit from the study results.
Why it matters
Potential benefit: If successful, using a VLMA could reduce airway blood contamination and postoperative throat pain, improving recovery and comfort after nasal surgery.
How similar studies have performed: Previous comparisons of supraglottic airway devices and endotracheal tubes have shown comparable ventilation and often less postoperative sore throat, but VLMA-specific data on preventing blood contamination during septoplasty are limited.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * ASA I-II classification patients * Patients aged 18-65 years undergoing elective septoplasty Exclusion Criteria: * ASA III-IV classification patients * Patients with anticipated difficult airway * Patients under 18 years of age * History of gastroesophageal reflux disease (GERD) or hiatal hernia * Body mass index (BMI) \>30 * Pregnant patients
Where this trial is running
Samsun, Ilkadim
- Samsun University, Samsun Training and Research Hospital — Samsun, Ilkadim, Turkey (Türkiye) (Recruiting)
Study contacts
- Study coordinator: Hatice Selcuk KUSDERCI, M.D.
- Email: drkusderci@hotmail.com
- Phone: +905052159896
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.